{"filing":{"accession_number":"0001062993-26-004898","cik":"0001997296","ticker":"MDCXW","company_name":"Medicus Pharma Ltd.","form":"8-K","filing_date":"2026-09-11","report_date":"2026-09-04","primary_document":"form8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1997296/000106299326004898/form8k.htm"},"events":[{"id":32824,"run_id":30176,"accession_number":"0001062993-26-004898","anchor_item_number":"3.02","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"summary":"The Company issued 8,529,412 restricted common shares to officers and employees in lieu of $1.45 million in cash bonuses, representing a dilutive unregistered equity issuance exempt under Section 4(a)(2). The substantial share count and conversion of cash compensation to equity is material to investors assessing capital structure and shareholder dilution, particularly at a small-cap issuer (Nasdaq Capital Market listing).","company_name":"Medicus Pharma Ltd.","ticker":"MDCXW","filing_date":"2026-09-11","form":"8-K","submitted_at":null,"items":[{"id":36092,"accession_number":"0001062993-26-004898","item_number":"3.02","item_title":"Unregistered Sales of Equity Securities.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"reasoning":"The Company issued 8,529,412 restricted common shares to officers and employees in lieu of $1.45 million in cash bonuses, representing a dilutive unregistered equity issuance exempt under Section 4(a)(2). The substantial share count and conversion of cash compensation to equity is material to investors assessing capital structure and shareholder dilution, particularly at a small-cap issuer (Nasdaq Capital Market listing).","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-11T12:02:17.450814+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":36092,"accession_number":"0001062993-26-004898","item_number":"3.02","item_title":"Unregistered Sales of Equity Securities.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"reasoning":"The Company issued 8,529,412 restricted common shares to officers and employees in lieu of $1.45 million in cash bonuses, representing a dilutive unregistered equity issuance exempt under Section 4(a)(2). The substantial share count and conversion of cash compensation to equity is material to investors assessing capital structure and shareholder dilution, particularly at a small-cap issuer (Nasdaq Capital Market listing).","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-11T12:02:17.450814+00:00","company_name":"Medicus Pharma Ltd.","ticker":"MDCXW","filing_date":"2026-09-11"}]}